Vaccine Aims at Fly Host of Disease Parasite
Jun 03, 2015•3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
An experimental leishmaniasis vaccine relies on eliciting an immune response to a protein from the saliva of the sand fly that carries the leishmania parasite, rather than on anything from the parasite itself. Cynthia Graber reports
Learn more about your ad choices. Visit megaphone.fm/adchoices
For the best experience, listen in Metacast app for iOS or Android